Host-directed therapy, an untapped opportunity for antimalarial intervention.

Area of Science:

• Parasitology
• Infectious Diseases
• Pharmacology

Background:

• Host-directed therapy (HDT) is an emerging strategy for infectious diseases, primarily targeting viral and bacterial infections.
• Its application in parasitic diseases, including malaria, remains underexplored.
• Untapped host targets present opportunities for novel antimalarial interventions.

Purpose of the Study:

• To provide an overview of host-directed therapy (HDT) in the context of parasitic diseases.
• To advocate for HDT as a promising antimalarial intervention strategy.
• To highlight the potential of HDT in rapidly addressing emerging infectious diseases.

Main Methods:

• Literature review and synthesis of existing research on HDT.
• Analysis of potential host targets for antimalarial drug development.
• Discussion of the advantages of HDT, including rapid deployment and resistance mitigation.

Main Results:

• HDT is a viable strategy for controlling intracellular pathogens.
• Repurposed drugs can be rapidly deployed through HDT.
• HDT is likely to significantly reduce the emergence of drug resistance.

Conclusions:

• Host-directed therapy (HDT) presents a promising avenue for antimalarial drug development.
• This approach offers advantages in combating drug resistance and enabling rapid treatment deployment.
• HDT is applicable to various intracellular pathogens and crucial for emerging infections.